177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer | MicrobiomeTrials← Back to trialsNCT06991738
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-09-16Est. Completion: 2032-07-01
Enrollment target: 18 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Thyroid Nodule
In this study, a randomized controlled study was conducted between two groups of 40 recipients of conventional flap duri…
Busan, South KoreaEst. completion Jun 30, 2024
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describ…
Kazan', RussiaEst. completion Dec 31, 2029
This study is to evaluate the effectiveness of nsPFA in treating papillary thyroid microcarcinoma. T
Sarasota, United StatesEst. completion Jan 31, 2029